Everything the press needs to know about Hilab
Materials, numbers, news, and why we do what we do.
Materials, numbers, news, and why we do what we do.
Friends and entrepreneurs, Marcus Figueredo and Sérgio Rogal founded Hi Technologies, now known as Hilab , a company that specializes in health tech.
Our lab testing service was born to expand access to healthcare to more people, with portable telemedicine devices that make diagnoses possible anywhere!
Pharmacies, Public Health, Clinics, Laboratories, Companies and Health Insurance Companies.
exams
patients
Currently, 50% of the Brazilian population is less than 6km away from a Hilab device and more than 2 million people have already taken one of our exams.
In March 2020, we were the first company in Brazil to launch a coronavirus test with results in minutes and a report signed by experts.
We created the Hilab Molecular, the first molecular biology testing device with results within 1 hour.
We participated with the Brazilian Federal Government in the Kayapó Mission in the north of the country, which took telemedicine to remote areas such as indigenous villages.
We participated in the Favela sem Corona (Favela without Corona) action in Rocinha, carrying out tests with community residents, which helped to detect positive cases and raise awareness among the population.
We co-developed the Tainá Platform, used by the Butantan Institute to centralize and manage epidemiological and vaccination data during the COVID-19 pandemic.
We collaborated on Project S, the first clinical study in the world for the effectiveness of CoronaVac in reducing the transmission of COVID-19, in partnership with Butantan Institute and the city of Serrana, in the state of São Paulo.
Between February and April, we maintained a 2.35% positivity with our mass testing strategy for COVID-19 at Hilab .
COVID-19 testing of Petrobras’ SIX and REPAR refineries employees since March 2021.
In April 2021, we launched the Hilab Testing Space for COVID-19 at Afonso Pena Airport in Curitiba.